MDXH Relative Valuation - MDxHealth SA - Alpha Spread
M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 2.63 USD 2.33% Market Closed
Market Cap: 71.8m USD
Have any thoughts about
MDxHealth SA?
Write Note

Relative Value

The Relative Value of one MDXH stock under the Base Case scenario is 13.11 USD. Compared to the current market price of 2.63 USD, MDxHealth SA is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MDXH Relative Value
Base Case
13.11 USD
Undervaluation 80%
Relative Value
Price
M
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
91
vs Industry
89
Median 3Y
1.7
Median 5Y
1.7
Industry
7.7
Forward
0.8
vs History
vs Industry
Median 3Y
-2.1
Median 5Y
-2.1
Industry
23.9
Forward
-2
vs History
vs Industry
22
Median 3Y
3.4
Median 5Y
3.4
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
N/A

Multiples Across Competitors

MDXH Competitors Multiples
MDxHealth SA Competitors

All Multiples
P/S
P/E
P/B
All Countries
Close
Market Cap P/S P/E P/B
BE
MDxHealth SA
NASDAQ:MDXH
71.8m USD 0.6 -1.2 -8.1
US
Abbvie Inc
NYSE:ABBV
341.9B USD 6.2 64.6 50.4
US
Amgen Inc
NASDAQ:AMGN
180.5B USD 5.8 57.7 30.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
129B USD 9.6 29.8 4.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD 12 -252.2 8.4
US
Gilead Sciences Inc
NASDAQ:GILD
104.5B USD 3.8 99.3 5.7
US
Epizyme Inc
F:EPE
94.1B EUR 1 981.8 -505.7 -5 179.8
AU
CSL Ltd
ASX:CSL
142.3B AUD 6.5 36.7 5.6
US
Seagen Inc
F:SGT
39.3B EUR 19.1 -58.5 17.2
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 24 355.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.4B USD 15.1 -485.3 -11 534.4
P/E Multiple
Earnings Growth
BE
M
MDxHealth SA
NASDAQ:MDXH
Average P/E: 57.6
Negative Multiple: -1.2
N/A
US
Abbvie Inc
NYSE:ABBV
64.6
406%
US
Amgen Inc
NASDAQ:AMGN
57.7
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.8
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -252.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
99.3
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
AU
CSL Ltd
ASX:CSL
36.7
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -485.3 N/A

See Also

Discover More
Back to Top